Mizuho’s Salim Syed returns to BiotechTV for Analyst Thursdays
- blonca9
- Oct 5, 2023
- 1 min read
Salim Syed talks about his recent initiation on CRISPR Therapeutics, and comments on Wave Life Sciences, BridgeBio, Atara, and Cytokinetics.
top of page
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.
bottom of page